Table of Contents
CHAPTER 1 INTRODUCTION
- 1.1 What is this report about?
- 1.2 Who is the target reader?
- 1.3 How to use this report
- 1.4 Definitions
CHAPTER 2 SCANDINAVIA OTC PHARMACEUTICALS INDUSTRY OUTLOOK
- 2.1 Market Analysis
- 2.2 Market Revenues
- 2.3 Market Segmentation
CHAPTER 3 OTC PHARMACEUTICALS IN DENMARK
- 3.1 Market Overview
- 3.2 Market Value
- 3.3 Market Segmentation I
- 3.4 Market Segmentation II
- 3.5 Market Share
- 3.6 Five Forces Analysis
- 3.7 Leading Companies
- 3.8 Distribution
- 3.9 Market Forecasts
- 3.10 Macroeconomic Indicators
CHAPTER 4 OTC PHARMACEUTICALS IN NORWAY
- 4.1 Market Overview
- 4.2 Market Value
- 4.3 Market Segmentation I
- 4.4 Market Segmentation II
- 4.5 Market Share
- 4.6 Five Forces Analysis
- 4.7 Leading Companies
- 4.8 Distribution
- 4.9 Market Forecasts
- 4.10 Macroeconomic Indicators
CHAPTER 5 OTC PHARMACEUTICALS IN SWEDEN
- 5.1 Market Overview
- 5.2 Market Value
- 5.3 Market Segmentation I
- 5.4 Market Segmentation II
- 5.5 Market Share
- 5.6 Five Forces Analysis
- 5.7 Leading Companies
- 5.8 Distribution
- 5.9 Market Forecasts
- 5.10 Macroeconomic Indicators
CHAPTER 6 APPENDIX
- 6.1 Data Research Methodology
LIST OF TABLES
- Table 1: Scandinavia OTC Pharmaceuticals industry, revenue ($m) 2004 -
2013 13
- Table 2: Scandinavia OTC Pharmaceuticals industry, revenue ($m) 2004 -
2008(e) 14
- Table 3: Scandinavia OTC Pharmaceuticals industry forecast, revenue ($m)
2008 - 2013 15
- Table 4: Denmark OTC Pharmaceuticals Market Value: $ million, 2004-2008(e)
18
- Table 5: Denmark OTC Pharmaceuticals Market Segmentation I: % Share, by
Value, 2008(e) 19
- Table 6: Denmark OTC Pharmaceuticals Market Segmentation II: % Share, by
Value, 2008(e) 20
- Table 7: Denmark OTC Pharmaceuticals Market Share: % Share, by Value, 2007
21
- Table 8: Key Facts: Novartis AG 28
- Table 9: Key Financials: Novartis AG 30
- Table 10: Key Facts: Pfizer Inc 31
- Table 11: Key Financials: Pfizer Inc 33
- Table 12: Key Facts: GlaxoSmithKline PLC 34
- Table 13: Key Financials: GlaxoSmithKline PLC 37
- Table 14: Denmark OTC Pharmaceuticals Distribution: % Share, by Value,
2008(e) 38
- Table 15: Denmark OTC Pharmaceuticals Market Value Forecast: $ million,
2008-2013 39
- Table 16: Denmark Size of Population (million) , 2004-2008(e) 40
- Table 17: Denmark GDP (Constant 2000 Prices, $ billion), 2004-2008(e) 40
- Table 18: Denmark Inflation, 2004-2008(e) 41
- Table 19: Denmark Exchange Rate, 2004-2008(e) 41
- Table 20: Norway OTC Pharmaceuticals Market Value: $ million, 2004-2008(e)
43
- Table 21: Norway OTC Pharmaceuticals Market Segmentation I: % Share, by
Value, 2008(e) 44
- Table 22: Norway OTC Pharmaceuticals Market Segmentation II: % Share, by
Value, 2008(e) 45
- Table 23: Norway OTC Pharmaceuticals Market Share: % Share, by Value, 2007
46
- Table 24: Key Facts: GlaxoSmithKline PLC 53
- Table 25: Key Financials: GlaxoSmithKline PLC 56
- Table 26: Key Facts: Pfizer Inc 57
- Table 27: Key Financials: Pfizer Inc 59
- Table 28: Key Facts: Novartis AG 60
- Table 29: Key Financials: Novartis AG 62
- Table 30: Norway OTC Pharmaceuticals Distribution: % Share, by Value,
2008(e) 63
- Table 31: Norway OTC Pharmaceuticals Market Value Forecast: $ million,
2008-2013 64
- Table 32: Norway Size of Population (million) , 2004-2008(e) 65
- Table 33: Norway GDP (Constant 2000 Prices, $ billion), 2004-2008(e) 65
- Table 34: Norway Inflation, 2004-2008(e) 66
- Table 35: Norway Exchange Rate, 2004-2008(e) 66
- Table 36: Sweden OTC Pharmaceuticals Market Value: $ million, 2004-2008(e)
68
- Table 37: Sweden OTC Pharmaceuticals Market Segmentation I: % Share, by
Value, 2008(e) 69
- Table 38: Sweden OTC Pharmaceuticals Market Segmentation II: % Share, by
Value, 2008(e) 70
- Table 39: Sweden OTC Pharmaceuticals Market Share: % Share, by Value, 2007
71
- Table 40: Key Facts: Pfizer Inc 78
- Table 41: Key Financials: Pfizer Inc 80Table 42: Key Facts:
Bayer AG 81
- Table 43: Key Financials: Bayer AG 84
- Table 44: Key Facts: Novartis AG 85
- Table 45: Key Financials: Novartis AG 87
- Table 46: Sweden OTC Pharmaceuticals Distribution: % Share, by Value,
2008(e) 88
- Table 47: Sweden OTC Pharmaceuticals Market Value Forecast: $ million,
2008-2013 89
- Table 48: Sweden Size of Population (million) , 2004-2008(e) 90
- Table 49: Sweden GDP (Constant 2000 Prices, $ billion), 2004-2008(e) 90
- Table 50: Sweden Inflation, 2004-2008(e) 91
- Table 51: Sweden Exchange Rate, 2004-2008(e) 91
LIST OF FIGURES
- Figure 1: Scandinavia OTC Pharmaceuticals industry, revenue ($m) 2004 -
2013 13
- Figure 2: Scandinavia OTC Pharmaceuticals industry, revenue ($m) 2004 -
2008(e) 14
- Figure 3: Scandinavia OTC Pharmaceuticals industry forecast, revenue ($m)
2008 - 2013 15
- Figure 4: Scandinavia OTC Pharmaceuticals industry, Segmentation (%) 2008
16
- Figure 5: Denmark OTC Pharmaceuticals Market Value: $ million,
2004-2008(e) 18
- Figure 6: Denmark OTC Pharmaceuticals Market Segmentation I: % Share, by
Value, 2008(e) 19
- Figure 7: Denmark OTC Pharmaceuticals Market Segmentation II: % Share, by
Value, 2008(e) 20
- Figure 8: Denmark OTC Pharmaceuticals Market Share: % Share, by Value,
2007 21
- Figure 9: Forces Driving Competition in the OTC Pharmaceuticals Market in
Denmark 22
- Figure 10: Drivers of Buyer Power in the OTC Pharmaceuticals Market in
Denmark 23
- Figure 11: Drivers of Supplier Power in the OTC Pharmaceuticals Market in
Denmark 24
- Figure 12: Factors Influencing the Likelihood of New Entrants in the OTC
Pharmaceuticals Market in Denmark 25
- Figure 13: Factors Influencing the Threat of Substitutes in the OTC
Pharmaceuticals Market in Denmark 26
- Figure 14: Drivers of Degree of Rivalry in the OTC Pharmaceuticals Market
in Denmark 27
- Figure 15: Revenues & Profitability: Novartis AG 30
- Figure 16: Revenues & Profitability: Pfizer Inc 33
- Figure 17: Revenues & Profitability: GlaxoSmithKline PLC 37
- Figure 18: Denmark OTC Pharmaceuticals Distribution: % Share, by Value,
2008(e) 38
- Figure 19: Denmark OTC Pharmaceuticals Market Value Forecast: $ million,
2008-2013 39
- Figure 20: Norway OTC Pharmaceuticals Market Value: $ million,
2004-2008(e) 43
- Figure 21: Norway OTC Pharmaceuticals Market Segmentation I: % Share, by
Value, 2008(e) 44
- Figure 22: Norway OTC Pharmaceuticals Market Segmentation II: % Share, by
Value, 2008(e) 45
- Figure 23: Norway OTC Pharmaceuticals Market Share: % Share, by Value,
2007 46
- Figure 24: Forces Driving Competition in the OTC Pharmaceuticals Market in
Norway 47
- Figure 25: Drivers of Buyer Power in the OTC Pharmaceuticals Market in
Norway 48
- Figure 26: Drivers of Supplier Power in the OTC Pharmaceuticals Market in
Norway 49
- Figure 27: Factors Influencing the Likelihood of New Entrants in the OTC
Pharmaceuticals Market in Norway 50
- Figure 28: Factors Influencing the Threat of Substitutes in the OTC
Pharmaceuticals Market in Norway 51
- Figure 29: Drivers of Degree of Rivalry in the OTC Pharmaceuticals Market
in Norway 52
- Figure 30: Revenues & Profitability: GlaxoSmithKline PLC 56
- Figure 31: Revenues & Profitability: Pfizer Inc 59
- Figure 32: Revenues & Profitability: Novartis AG 62
- Figure 33: Norway OTC Pharmaceuticals Distribution: % Share, by Value,
2008(e) 63
- Figure 34: Norway OTC Pharmaceuticals Market Value Forecast: $ million,
2008-2013 64
- Figure 35: Sweden OTC Pharmaceuticals Market Value: $ million,
2004-2008(e) 68
- Figure 36: Sweden OTC Pharmaceuticals Market Segmentation I: % Share, by
Value, 2008(e) 69
- Figure 37: Sweden OTC Pharmaceuticals Market Segmentation II: % Share, by
Value, 2008(e) 70
- Figure 38: Sweden OTC Pharmaceuticals Market Share: % Share, by Value,
2007 71
- Figure 39: Forces Driving Competition in the OTC Pharmaceuticals Market in
Sweden 72
- Figure 40: Drivers of Buyer Power in the OTC Pharmaceuticals Market in
Sweden 73
- Figure 41: Drivers of Supplier Power in the OTC Pharmaceuticals Market in
Sweden 74
- Figure 42: Factors Influencing the Likelihood of New Entrants in the OTC
Pharmaceuticals Market in Sweden 75
- Figure 43: Factors Influencing the Threat of Substitutes in the OTC
PharmaceuticalsMarket in Sweden 76
- Figure 44: Drivers of Degree of Rivalry in the OTC Pharmaceuticals Market
in Sweden 77
- Figure 45: Revenues & Profitability: Pfizer Inc 80
- Figure 46: Revenues & Profitability: Bayer AG 84
- Figure 47: Revenues & Profitability: Novartis AG 87
- Figure 48: Sweden OTC Pharmaceuticals Distribution: % Share, by Value,
2008(e) 88
- Figure 49: Sweden OTC Pharmaceuticals Market Value Forecast: $ million,
2008-2013 89
|
Related Report
|
View Cart
